Management Recommendation
Based on these CT findings showing polypoid mucosal thickening in the right maxillary sinus with bilateral disease and osteomeatal complex narrowing, you should initiate medical management with intranasal corticosteroids and consider referral to an otolaryngologist for surgical evaluation if symptoms persist after appropriate medical therapy. 1
Initial Medical Management
Start with intranasal corticosteroids as first-line therapy. The presence of polypoid changes indicates this patient likely has chronic rhinosinusitis with polyps (CRSwNP), which responds to topical corticosteroid therapy 2.
Key point: The 2025 AAO-HNS guideline explicitly states that surgeons should NOT plan surgery solely based on arbitrary criteria regarding mucosal thickening or sinus opacification on CT 1. The decision must be based on clinical symptoms, quality of life impact, and failure of appropriate medical management.
When to Consider Surgical Referral
Refer to otolaryngology if the patient:
- Has failed appropriate medical therapy (intranasal corticosteroids for adequate duration)
- Experiences significant quality of life impairment
- Has specific high-risk features on imaging
The polypoid mucosal thickening in your patient's right maxillary sinus is particularly relevant - the 2025 guideline identifies CRS with polyps as a subtype that benefits most from surgery and is least likely to benefit from continued medical therapy alone 1. When polyps are present, surgery should include full exposure of the sinus cavity and removal of diseased tissue, not just ostial dilation 1.
Critical Caveats
Do not treat with antibiotics based on these CT findings alone. Research demonstrates that mucosal thickening without fluid levels or complete opacification does not benefit from antibiotic therapy 3. Antibiotics should only be used when symptoms indicate acute infection (pain or purulence) 2.
Isolated mucosal thickening is common in asymptomatic individuals 4, so correlation with clinical symptoms is essential. The diagnosis of CRS requires both symptom duration (≥12 weeks) AND objective evidence of inflammation 2.
Surgical Planning Considerations
If surgery becomes necessary, the CT shows:
- Right osteomeatal complex narrowing requiring attention
- Bilateral ethmoid involvement (73% of surgical candidates show ethmoid disease) 4
- Polypoid changes requiring complete tissue removal rather than simple dilation 1
- Minimally deviated septum (unlikely to require septoplasty unless obstructing surgical access)
The patient should understand that surgery requires long-term postoperative medical management and follow-up between 3-12 months to assess outcomes 1. There is potential for disease recurrence requiring revision surgery.